JP2023511062A5 - - Google Patents
Info
- Publication number
- JP2023511062A5 JP2023511062A5 JP2022542394A JP2022542394A JP2023511062A5 JP 2023511062 A5 JP2023511062 A5 JP 2023511062A5 JP 2022542394 A JP2022542394 A JP 2022542394A JP 2022542394 A JP2022542394 A JP 2022542394A JP 2023511062 A5 JP2023511062 A5 JP 2023511062A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- disease
- protein
- viral vector
- igg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062964565P | 2020-01-22 | 2020-01-22 | |
| US62/964,565 | 2020-01-22 | ||
| PCT/US2021/014770 WO2021151004A1 (en) | 2020-01-22 | 2021-01-22 | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023511062A JP2023511062A (ja) | 2023-03-16 |
| JP2023511062A5 true JP2023511062A5 (https=) | 2024-01-16 |
Family
ID=76992653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542394A Pending JP2023511062A (ja) | 2020-01-22 | 2021-01-22 | 遺伝子療法ベクターの形質導入を増加又は増強するための及び免疫グロブリンを除去又は低減するための組成物及び方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230241247A1 (https=) |
| EP (1) | EP4093436A4 (https=) |
| JP (1) | JP2023511062A (https=) |
| KR (1) | KR20220161268A (https=) |
| CN (1) | CN115135343A (https=) |
| AU (1) | AU2021211730A1 (https=) |
| BR (1) | BR112022014264A2 (https=) |
| CA (1) | CA3165025A1 (https=) |
| CL (1) | CL2022001984A1 (https=) |
| CO (1) | CO2022011195A2 (https=) |
| IL (2) | IL325936A (https=) |
| MX (1) | MX2022009065A (https=) |
| PE (1) | PE20221780A1 (https=) |
| PH (1) | PH12022551843A1 (https=) |
| WO (1) | WO2021151004A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113660938A (zh) * | 2019-01-30 | 2021-11-16 | 国立研究开发法人国立精神·神经医疗研究中心 | 核酸递送复合物 |
| JP2024546152A (ja) * | 2021-12-16 | 2024-12-17 | 上海宝済薬業股▲ふん▼有限公司 | 免疫グロブリン分解酵素による切断に対抗するＦｃ変異体 |
| WO2023116817A1 (zh) * | 2021-12-22 | 2023-06-29 | 上海宝济药业有限公司 | 一种免疫球蛋白降解酶IdeE的突变体的用途 |
| CN116621988A (zh) * | 2022-02-10 | 2023-08-22 | 中国科学院上海药物研究所 | 一类亲和片段共价修饰的糖苷内切酶，其制备方法及在糖蛋白的糖基化改造中的应用 |
| CN117126270B (zh) * | 2023-10-25 | 2024-02-13 | 首都儿科研究所 | 一种2型人博卡病毒型别特异性抗体及其应用 |
| WO2025178891A1 (en) * | 2024-02-19 | 2025-08-28 | The Trustees Of Columbia University In The City Of New York | Targeting immunoglobulin for treating aging and metabolic diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200745163A (en) * | 2006-02-17 | 2007-12-16 | Syntonix Pharmaceuticals Inc | Peptides that block the binding of IgG to FcRn |
| US10336825B2 (en) * | 2014-04-30 | 2019-07-02 | Hanall Biopharma Co., Ltd. | Antibody binding to FcRn for treating autoimmune diseases |
| GB201502305D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| AU2021292200A1 (en) * | 2020-06-17 | 2023-02-02 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of gene therapy patients |
-
2021
- 2021-01-21 IL IL325936A patent/IL325936A/en unknown
- 2021-01-22 PH PH1/2022/551843A patent/PH12022551843A1/en unknown
- 2021-01-22 IL IL294558A patent/IL294558B1/en unknown
- 2021-01-22 AU AU2021211730A patent/AU2021211730A1/en active Pending
- 2021-01-22 CN CN202180010462.XA patent/CN115135343A/zh active Pending
- 2021-01-22 CA CA3165025A patent/CA3165025A1/en active Pending
- 2021-01-22 KR KR1020227028570A patent/KR20220161268A/ko active Pending
- 2021-01-22 EP EP21743720.1A patent/EP4093436A4/en active Pending
- 2021-01-22 PE PE2022001463A patent/PE20221780A1/es unknown
- 2021-01-22 JP JP2022542394A patent/JP2023511062A/ja active Pending
- 2021-01-22 BR BR112022014264A patent/BR112022014264A2/pt unknown
- 2021-01-22 WO PCT/US2021/014770 patent/WO2021151004A1/en not_active Ceased
- 2021-01-22 MX MX2022009065A patent/MX2022009065A/es unknown
- 2021-01-22 US US17/759,183 patent/US20230241247A1/en active Pending
-
2022
- 2022-07-21 CL CL2022001984A patent/CL2022001984A1/es unknown
- 2022-08-09 CO CONC2022/0011195A patent/CO2022011195A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023511062A5 (https=) | ||
| CN104520428B (zh) | 将基因转移到细胞、器官和组织的aav载体组合物和方法 | |
| JP2023179414A (ja) | アフェレーシスの方法及び使用 | |
| JP2020530834A5 (https=) | ||
| JP2020528734A5 (https=) | ||
| JP2023113706A (ja) | 細胞トランスフェクション及び／又はｒＡＡＶベクター産生の改善のための増強剤 | |
| JP2024073614A (ja) | プラスミドを用いないａａｖベクター産生細胞株 | |
| JP2021529821A5 (https=) | ||
| JP2015509711A5 (https=) | ||
| IL276192A (en) | Different AAV and preparations, methods and uses for transferring genes to cells, organs and tissues | |
| CN112689515A (zh) | 用于增加或增强基因治疗载体的转化以及用于去除或减少免疫球蛋白的组合物和方法 | |
| IL259595B2 (en) | Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use | |
| IL299325B2 (en) | Acid-alpha glucosidase variants and uses thereof | |
| EP4004214A1 (en) | Engineered nucleic acid regulatory element and methods of uses thereof | |
| AU2022214192A1 (en) | Compositions and methods for treating hereditary angioedema | |
| US20240271159A1 (en) | Aav vector column purification methods | |
| RU2021100780A (ru) | Композиции и способы для повышения или усиления трансдукции векторов для генной терапии и для удаления или снижения иммуноглобулинов | |
| JP2025533347A (ja) | 遺伝子治療のための共処置 | |
| US20260000670A1 (en) | Prevention or mitigation of adverse effects related to recombinant viral vectors | |
| RU2849598C2 (ru) | Композиции и способы для повышения или усиления трансдукции векторов для генной терапии и для удаления или снижения иммуноглобулинов | |
| WO2025264490A1 (en) | Dna promoters | |
| JP2025534660A (ja) | エピソーム遺伝子を制御発現させるための遺伝子編集 |